1. Development of fluorizoline analogues as prohibitin ligands that modulate C-RAF signaling, p21 expression and melanogenesis
- Author
-
Nora Chouha, Hussein Abou-Hamdan, Hajime Yurugi, Riku Yoshii, Hiromi Ii, Ahmad Najem, Ghanem E. Ghanem, Susumu Nakata, Krishnaraj Rajalingam, Yu Peng, Dong Wang, Canan G. Nebigil, Laurent Désaubry, Nanomédecine Régénérative (NanoRegMed), Université de Strasbourg (UNISTRA)-Institut National de la Santé et de la Recherche Médicale (INSERM), Centre de Recherche en Biomédecine de Strasbourg (CRBS), Laboratoire de Chimie et Chimie de l'Environnement (LCCE), Université Hadj Lakhdar Batna 1, University Medical Center [Mainz], Kyoto University, Institut Jules Bordet [Bruxelles], Faculté de Médecine [Bruxelles] (ULB), Université libre de Bruxelles (ULB)-Université libre de Bruxelles (ULB), Université libre de Bruxelles (ULB), Tianjin University of Science and Technology (TUST), Xinjiang University, and univOAK, Archive ouverte
- Subjects
Cyclin-Dependent Kinase Inhibitor p21 ,Melanins ,Pharmacology ,Melanogenesis ,p21 ,[CHIM.THER] Chemical Sciences/Medicinal Chemistry ,Organic Chemistry ,Apoptosis ,General Medicine ,Heterocycles ,[CHIM.THER]Chemical Sciences/Medicinal Chemistry ,Protein Serine-Threonine Kinases ,Ligands ,Proto-Oncogene Proteins c-raf ,Repressor Proteins ,MAP kinases ,Proto-Oncogene Proteins ,Drug Discovery ,Prohibitins ,Humans ,Chimie/Chimie thérapeutique ,HeLa Cells ,Transcription Factors ,Cancer - Abstract
Fluorizoline is a cytotoxic trifluorothiazoline that targets the scaffold proteins prohibitins-1 and -2 (PHB1/2) to inhibit the kinase C-RAF and promote the expression of the cyclin-dependent kinase inhibitor p21 to induce cancer cell death. In melanocytes, fluorizoline also induces the synthesis of melanin. Herein we report the first structural requirement of fluorizoline analogues for these activities. We identified in particular some compounds that display enhanced anti-C-RAF and anti-MEK activities, and a higher cytotoxicity in HeLa cells compared to fluorizoline. These results provide a foundation for further optimization of PHB ligands for the treatment of cancers. We also discovered an analogue of fluorizoline that displays pharmacological effects opposed to those of fluorizoline and that can be used as a chemical tool to explore PHB signaling in cancers and other diseases.
- Published
- 2022